DoD Prostate Cancer Research Program anticipated funding opportunities for FY23

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

The Trump administration has a fight on its hands as it pushes forward with a plan to exert greater political control over government funding of science.

ARPA-H awards up to $160M to advance personalized curative medicines for rare genetic diseases

The Advanced Research Projects Agency for Health, an agency within the U.S. Department of Health and Human Services, announced the teams for the Treating Hereditary Rare Diseases with In Vivo Precision Genetic Medicines (THRIVE) program—a critical investment toward bringing new treatments to patients faster and curing rare genetic pediatric diseases.

July 10, 2026

Vol.52 No.27

In Brief

Cancer Research Institute issues 93 awards totaling $37 million

The Cancer Research Institute announced its largest-ever annual grantmaking—93 awards totaling $37 million—as federal funding for cancer research remains uncertain.

July 10, 2026

Vol.52 No.27

Clinical Roundup

Should lowest-risk prostate cancer still be called “cancer”? UCLA-led study suggests changing the name could save lives

A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer “cancer” does more harm than good. A UCLA-led study found removing the cancer label could dramatically reduce overtreatment and encourage more men to get screened, potentially leading to significantly fewer deaths from aggressive prostate cancer.

July 10, 2026

Vol.52 No.27

Cancer Policy

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

Democratic leaders of the House Committee on Energy and Commerce are urging NIH Director Jay Bhattacharya to voice objections to a proposed rule from the Office of Management and Budget that would give the administration unprecedented political control over government-funded science.

June 26, 2026

Vol.52 No.25

By Jacquelyn Cobb

Funding Opportunities

The Foundation for AIDS Research opens RFP to fund non-HIV cancer research

Historically, the research initiatives of the Foundation for AIDS Research (amfAR) have focused on finding a cure for HIV. Four decades of HIV research have reshaped our understanding of the immune system, and insights from HIV have been leveraged in adjacent fields, including cancer immunology. Innovation can be bi-directional and reciprocal. Seminal findings in cancer immunology have also furthered understanding of HIV biology.

June 26, 2026

Vol.52 No.25

DoD Prostate Cancer Research Program anticipated funding opportunities for FY23

YOU MAY BE INTERESTED IN

OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill

ARPA-H awards up to $160M to advance personalized curative medicines for rare genetic diseases

Cancer Research Institute issues 93 awards totaling $37 million

Should lowest-risk prostate cancer still be called “cancer”? UCLA-led study suggests changing the name could save lives

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

The Foundation for AIDS Research opens RFP to fund non-HIV cancer research

Renew today!

Subscriber content

Never miss an issue!

Login